期刊文献+

浅表性膀胱移行细胞癌复发与CDH1基因启动子C/A编码区单核苷酸多态性的关系 被引量:1

Association between the recurrence of superficial transitional cell carcinoma of bladder and the C/A single nucleotide polymorphism of CDH1 gene promoter
原文传递
导出
摘要 目的探讨CDH1基因启动子160C/A编码区单核苷酸多态性(cSNP)和浅表性膀胱移行细胞癌(STCCB)的复发之间的关系。方法健康对照组50例,无复发STCCB组33例,复发STCCB组28例,其中复发组按复发后有无临床分期和病理分级的升高分为进展组(10例)和非进展组(18例);PCRRFLP技术检测各组样本CDH1基因启动子160位点基因型。结果复发STCCB组该位点A等位基因频率(0.66)高于无复发STCCB组(0.48),P<0.05,差异有统计学意义;携带A等位基因的STCCB患者治疗后复发的危险性高于C等位基因携带者,OR值3.54,95%CI为1.52~5.73。结论CDH1基因启动子160A等位基因与浅表性膀胱移行细胞癌的复发密切相关。 Objective To investigate the association between the CDH1 gene promoter single nucleotide polymorphism and the recurrence of superficial transitional cell carcinoma of bladder (STCCB).Methods Normal population (n=50) and patients with STCCB (n=85) were observed.In STCCB group,all cases received TUR-Bt and following intravesical instillation chemiotherapy.After a follow-up of 5 years,STCCB group was divided into recurrence subgroup and non-recurrence subgroup according to the results of follow-up,and the recurrence subgroup was assigned into advance group (with advance of clinical stage and pathological grade) and non-advance group (without advance of clinical stage and pathological grade).The genotypes at 160 position of CDH1 gene promoter in STCCB patients and normal population were detected by PCR-RFLP.Results The A allele frequencies at -160 position of CDH1herin gene promoter were higher in recurrence subgroup of STCCB (0.66) than in non-recurrence subgroup (0.48), P< 0.05 and A-allele carriers with STCCB had a higher relative risk of recurrence (OR= 3.54,95% CI 1.52- 5.73) compared to C-only carriers.Conclusion A C/A single nucleotide polymorphism at position -160 from the transcription start site of CDH1herin gene promoter was closely related to the recurrence of STCCB.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第7期868-870,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30471737)
  • 相关文献

参考文献6

二级参考文献13

  • 1Serth J, Kuczyk MA, Bokemeyer C, et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer, 1995. 71 : 201-205.
  • 2Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol, 1995, 121 : 303-306.
  • 3Shariat SF, Pahlavan S, Baseman AG, et al. E-cadlherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.Urology, 2001, 57: 60-65.
  • 4Zhang HT, Craft P, Scott PA, etal. Enhancement of tumor growth and vascularity by transfection of vascular endothelial growth factor into MCF-7 cells breast carcinoma cells. J Nail Cancer Inst, 1995, 87: 213-219.
  • 5Chow NH, Liu HS, Chan SH, et al. Expression of vascular endolhelial growth factor in primary superficial bladder cancer. Anticancer Res,1999. 19: 4593-4597.
  • 6Pycha A, Mian C, Hoibauer J, et al. Multifocality of transitional cellcarcinoma results from genetic instability of entire transitional epithelium.Urology, 1999, 53: 92-97.
  • 7Andres RA, Salvador PF, Joaquin GG, et al. Multivariate analysis of survival recurrence progression and development d metastasis in T1 andT2a Transitional Cell Bladder Carcinoma. Cancer, 2002.94: 1677-1684.
  • 8Allard P, Bemard P, Frader Y, et al. The early clinical course of primary Ta and T1 bladder cancer : a proposed prognostic indet. Br J Urol, 1998, 81: 692-698.
  • 9Holmang S, Hedelin H, Anderstrom C, et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol, 1995, 153: 1823-1827.
  • 10Brausi M, Collette L, Kxulh K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol, 2002, 41 : 523-531.

共引文献38

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部